ReferIndia News oncology prescription business of Khandelwal Labs' for Rs 325 crore

ReferIndia News

Dr. Aditya Manke

Dr. Aditya Manke — Expert Robotic & Laparoscopic Cancer Surgeon. Precise care, faster recovery.

Contact Now
News Image

oncology prescription business of Khandelwal Labs' for Rs 325 crore

Published on: Jan. 1, 2026, 7:28 p.m. | Source: Times of India

India Business News: HYDERABAD: Pharma major Aurobindo Pharma is acquiring the non-oncology prescription business of Mumbai-based Khandelwal Laboratories Pvt Ltd on a goin.

Checkout more news
Ad Banner

Grow. Protect. Prosper.

Your wealth deserves expert care. Our advisors craft personalized investment plans designed to grow and safeguard your assets.

Schedule Call
ReferIndia News contact